Rheumatoid Arthritis Clinical Research Studies


Investigating an implantable Vagus-nerve-stimulator device as a treatment for RA. Patient compensation available, no cost to you!

Who’s eligible?

  • Patients age 22-75 with moderate to severe rheumatoid arthritis
  • Currently on a CsDMARD (methotrexate, hydroxychloroquine, Leflunomide, sulfasalazine)
  • Inadequate or loss of response to a RA biologic
  • Trial participation: 4 months – 3.8 years

If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring by a research doctor.

web button apply now to participate in a clinical research trial

For additional details or if you have questions, please call (425) 248-2635 or email ahubble@wwmedgroup.com.

More info on this study: https://reset-ra.study